Organigram Reports Record Fourth Quarter and Fiscal 2025 Results

Executive Summary

• Organigram reported record fiscal‑2025 results: gross revenue $403.0 M (+63% YoY) and adjusted EBITDA $21.9 M (+160% YoY).
• International sales surged to $26.3 M, a 173% increase year‑over‑year, driven by new product launches and recent acquisitions (Motif Labs Ltd. and Collective Project Limited).
• The company announced an upcoming conference call on December 16, 2025 to discuss the results and provided forward‑looking guidance for fiscal 2026 revenue > $300 M.

Key Details

• Fiscal 2025 Financial Highlights
• Gross Revenue: $403.0 M (+63% YoY)
• Net Revenue: $259.2 M (+62% YoY)
• Adjusted Gross Margin: $91.0 M (35% of net revenue)
• Adjusted EBITDA: $21.9 M (+160% YoY)

• Net Loss: $(24.8 M) (down 46% from prior year)

• Q4 2025 Financial Highlights

• Gross Revenue: $123.3 M (+76% YoY)
• Net Revenue: $80.1 M (+79% YoY)

• Adjusted EBITDA: $9.8 M (+69% YoY)

• International Business

• Record International Sales: $26.3 M, up 173% YoY (vs. $9.7 M in FY 2024).

• Launched “happly” edibles powered by FAST™ technology in the U.S.

• Acquisitions & Strategic Initiatives

• Acquired Motif Labs Ltd. – expanded Ontario footprint, extraction capacity; realized ~$7.1 M of $15 M identified synergies to date.
• Acquired Collective Project Limited – entry into Canadian and U.S. cannabinoid‑beverage markets.

• Launched FAST™ platform for ingestible products.

• Operational Highlights

• Record harvest achieved via seed‑based cultivation, upgraded lighting, and improved room turns.

• Identified genetic markers for powdery mildew resistance; breeding program underway.

• Balance Sheet (as of Sept 30 2025)

• Cash & short‑term investments: $84.4 M (down 37% YoY).
• Total assets: $562.2 M, up 37% YoY.

• Total liabilities: $213.1 M, up 109% YoY.

• Guidance for Fiscal 2026

• Expected net revenue > $300 M.

• Anticipated margin expansion from continued domestic/international demand and operational efficiencies.

• Conference Call Details

• Date: December 16, 2025, 8:00 am ET.
• Registration link: https://registrations.events/direct/Q4I9676638
• Webcast replay available on Organigram’s investor site within 24 hours and retained for 90 days.

Notable Quotes

• “Fiscal 2025 was marked by purposeful growth… Our acquisitions broadened our capabilities… We expanded our international presence…” – Peter Amirault, Executive Chair
• “Looking to Fiscal 2026, we believe we are well‑positioned for strong revenue growth with net revenue expected to exceed $300 million…” – Greg Guyatt, CFO